-Down to Earth Japan's Sapporo brewery patents Indian barley gene without giving benefit to farmers Ballia district, the easternmost part of Uttar Pradesh, is a flood-prone area that extends towards Bihar from the confluence of the Ganga and the Ghaghra. Over decades, its farmers, mostly marginal and small, have been cultivating barley, exchanging its seeds, improving the varieties and giving these to a government project to cull the best of the lot....
More »SEARCH RESULT
Polio battle won, war not over -GS Mudur
-The Telegraph India will celebrate three years without a single case of polio caused by the wild poliovirus on Tuesday, but public health experts have said the "endgame" to eradicate polio from the country will begin only next year and might last until 2018. The Union health ministry has planned a celebratory event at a stadium here, inviting India's political leaders, World Health Organisation (WHO) officials, international agencies, and over 1000...
More »Pills for polls-Kundan Pandey
-Down to Earth The free medicine scheme in Rajasthan may benefit Congress Of the many poll sops that Rajasthan Chief Minister Ashok Gehlot doled out in the past two years, the one scheme that seems to have struck the right chord with voters is the initiative to give free essential medicines at government healthcare facilities. The Mukhyamantri Nishulk Dava Yojna, launched in 2011, has offered some hope to the incumbent Congress government,...
More »Unethical collusion tag on vaccine campaign
-The Telegraph Two Union government health agencies colluded with a foreign entity to conduct a mass vaccination campaign on thousands of girls in India four years ago, violating medical ethics and national laws, a parliamentary committee said today. The parliamentary standing committee on health and family welfare has blamed the Indian Council of Medical Research (ICMR) and the Drugs Controller General of India for collaborating with the US-based Program for Appropriate Technologies...
More »Paying the price-Ramya Kannan
-The Hindu The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...
More »